MapLight Therapeutics, Inc.

Analyst research, target price, syndicate analytics, and valuation sections are included with an active subscription. View plans

Symbol

MPLT

Event Date

2025-10-27

Sector

Health Care

Subsector

Pharmaceuticals

Offer Range

—

Shares Offered

14.75M

Total Shares Post-IPO

430.46M

Market Cap

—

Target Price

$00.00

Implied Upside vs Midpoint

$00.00

Description

—

Post-IPO economic shares by class.

Class	Shares	% Economic
Common Stock standard voting rights; pre-IPO common stockholders hold 789,241 shares (post reverse-stock-split equivalent) as of June 30, 2025	789.24K	0.2%
Non-Voting Common Stock non-voting; 2,727,511 shares represent a portion of the 25,412,974 total shares into which all preferred stock converts at IPO	2.73M	0.6%
Series A Redeemable Convertible Preferred Stock converts to common stock at IPO; liquidation preference $5M	5M	1.2%
Series A-1 Redeemable Convertible Preferred Stock converts to common stock at IPO; liquidation preference $16M	14.95M	3.5%
Series B Redeemable Convertible Preferred Stock converts to common stock at IPO; liquidation preference $53M	45.01M	10.5%
Series B-1 Redeemable Convertible Preferred Stock converts to common stock at IPO; liquidation preference $12M	4.62M	1.1%
Series C Redeemable Convertible Preferred Stock converts to common stock at IPO; liquidation preference $225M; multiple rounds issued 2023-2024 totaling ~$225M gross	147.33M	34.2%
Series D Redeemable Convertible Preferred Stock issued July-September 2025 at $0.95223/share for $200M gross proceeds; converts to common at IPO as part of the 25,412,974 total common conversion	210.03M	48.8%
Total economic shares	430.46M	100%

████████████████████